Received Sep 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (JANSSEN)) | JANSSEN | 1 | 1805018 | IM / LA |
Received Janssen (Johnson & Johnson) COVID-19 vaccine (Ad26.COV2.S). Soon after, developed chest pain/tightness, elevated heart rate, and a marked decline in running performance/exercise tolerance. Cardiology evaluation included EKG, exercise stress test, nuclear perfusion study (radioactive tracer), and echocardiogram. No prior cardiac history.
None
None
None
None
Cardiology evaluation in June/July 2021 included EKG, exercise treadmill stress test, nuclear perfusion (radioactive tracer) scan, and echocardiogram (ultrasound). No prior cardiac history.